TRIM29 and prostate carcinoma: TRIM29 is selectively expressed in basal cells of the normal prostate gland, and immunohistochemical staining with anti-TRIM29 antibody showed the same expression pattern as that with 34βE12 in prostate cancer and its benign mimics, indicating that TRIM29 may be useful for distinguishing prostate cancers from benign tissues [18].